Evidence-based treatment of carotid artery stenosis

Kate C. Young, Anunaya Jain, Minal Jain, Robert E. Replogle, Curtis G. Benesch, Babak S. Jahromi*

*Corresponding author for this work

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Carotid atheromatous disease is an important cause of stroke. Carotid endarterectomy (CEA) is a well-established option for reducing the risk of subsequent stroke due to symptomatic stenosis (> 50%). With adequately low perioperative risk (< 3%) and sufficient life expectancy, CEA may be used for asymptomatic stenosis (> 60%). Recently, carotid angioplasty and stent placement (CAS) has emerged as an alternative revascularization technique. Trial design considerations are discussed in relation to trial results to provide an understanding of why some trials were considered positive whereas others were not. This review then addresses both the original randomized studies showing that CEA is superior to best medical management and the newer studies comparing the procedure to stent insertion in both symptomatic and asymptomatic populations. Additionally, recent population-based studies show that improvements in best medical management may be lowering the stroke risk for asymptomatic stenosis. Finally, the choice of revascularization technique is discussed with respect to symptom status. Based on current evidence, CAS should remain limited to specific indications.

Original languageEnglish (US)
Article numberE2
JournalNeurosurgical focus
Volume30
Issue number6
DOIs
StatePublished - Jun 1 2011

Fingerprint

Carotid Stenosis
Stents
Carotid Endarterectomy
Stroke
Angioplasty
Pathologic Constriction
Population
Therapeutics

Keywords

  • Carotid angioplasty and stent placement
  • Carotid endarterectomy
  • Evidence-based medicine

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Young, K. C., Jain, A., Jain, M., Replogle, R. E., Benesch, C. G., & Jahromi, B. S. (2011). Evidence-based treatment of carotid artery stenosis. Neurosurgical focus, 30(6), [E2]. https://doi.org/10.3171/2011.3.FOCUS1143
Young, Kate C. ; Jain, Anunaya ; Jain, Minal ; Replogle, Robert E. ; Benesch, Curtis G. ; Jahromi, Babak S. / Evidence-based treatment of carotid artery stenosis. In: Neurosurgical focus. 2011 ; Vol. 30, No. 6.
@article{b12f81929bd14bdf8a231a4f209e5ab5,
title = "Evidence-based treatment of carotid artery stenosis",
abstract = "Carotid atheromatous disease is an important cause of stroke. Carotid endarterectomy (CEA) is a well-established option for reducing the risk of subsequent stroke due to symptomatic stenosis (> 50{\%}). With adequately low perioperative risk (< 3{\%}) and sufficient life expectancy, CEA may be used for asymptomatic stenosis (> 60{\%}). Recently, carotid angioplasty and stent placement (CAS) has emerged as an alternative revascularization technique. Trial design considerations are discussed in relation to trial results to provide an understanding of why some trials were considered positive whereas others were not. This review then addresses both the original randomized studies showing that CEA is superior to best medical management and the newer studies comparing the procedure to stent insertion in both symptomatic and asymptomatic populations. Additionally, recent population-based studies show that improvements in best medical management may be lowering the stroke risk for asymptomatic stenosis. Finally, the choice of revascularization technique is discussed with respect to symptom status. Based on current evidence, CAS should remain limited to specific indications.",
keywords = "Carotid angioplasty and stent placement, Carotid endarterectomy, Evidence-based medicine",
author = "Young, {Kate C.} and Anunaya Jain and Minal Jain and Replogle, {Robert E.} and Benesch, {Curtis G.} and Jahromi, {Babak S.}",
year = "2011",
month = "6",
day = "1",
doi = "10.3171/2011.3.FOCUS1143",
language = "English (US)",
volume = "30",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "6",

}

Young, KC, Jain, A, Jain, M, Replogle, RE, Benesch, CG & Jahromi, BS 2011, 'Evidence-based treatment of carotid artery stenosis', Neurosurgical focus, vol. 30, no. 6, E2. https://doi.org/10.3171/2011.3.FOCUS1143

Evidence-based treatment of carotid artery stenosis. / Young, Kate C.; Jain, Anunaya; Jain, Minal; Replogle, Robert E.; Benesch, Curtis G.; Jahromi, Babak S.

In: Neurosurgical focus, Vol. 30, No. 6, E2, 01.06.2011.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evidence-based treatment of carotid artery stenosis

AU - Young, Kate C.

AU - Jain, Anunaya

AU - Jain, Minal

AU - Replogle, Robert E.

AU - Benesch, Curtis G.

AU - Jahromi, Babak S.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Carotid atheromatous disease is an important cause of stroke. Carotid endarterectomy (CEA) is a well-established option for reducing the risk of subsequent stroke due to symptomatic stenosis (> 50%). With adequately low perioperative risk (< 3%) and sufficient life expectancy, CEA may be used for asymptomatic stenosis (> 60%). Recently, carotid angioplasty and stent placement (CAS) has emerged as an alternative revascularization technique. Trial design considerations are discussed in relation to trial results to provide an understanding of why some trials were considered positive whereas others were not. This review then addresses both the original randomized studies showing that CEA is superior to best medical management and the newer studies comparing the procedure to stent insertion in both symptomatic and asymptomatic populations. Additionally, recent population-based studies show that improvements in best medical management may be lowering the stroke risk for asymptomatic stenosis. Finally, the choice of revascularization technique is discussed with respect to symptom status. Based on current evidence, CAS should remain limited to specific indications.

AB - Carotid atheromatous disease is an important cause of stroke. Carotid endarterectomy (CEA) is a well-established option for reducing the risk of subsequent stroke due to symptomatic stenosis (> 50%). With adequately low perioperative risk (< 3%) and sufficient life expectancy, CEA may be used for asymptomatic stenosis (> 60%). Recently, carotid angioplasty and stent placement (CAS) has emerged as an alternative revascularization technique. Trial design considerations are discussed in relation to trial results to provide an understanding of why some trials were considered positive whereas others were not. This review then addresses both the original randomized studies showing that CEA is superior to best medical management and the newer studies comparing the procedure to stent insertion in both symptomatic and asymptomatic populations. Additionally, recent population-based studies show that improvements in best medical management may be lowering the stroke risk for asymptomatic stenosis. Finally, the choice of revascularization technique is discussed with respect to symptom status. Based on current evidence, CAS should remain limited to specific indications.

KW - Carotid angioplasty and stent placement

KW - Carotid endarterectomy

KW - Evidence-based medicine

UR - http://www.scopus.com/inward/record.url?scp=79958795290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958795290&partnerID=8YFLogxK

U2 - 10.3171/2011.3.FOCUS1143

DO - 10.3171/2011.3.FOCUS1143

M3 - Article

C2 - 21631221

AN - SCOPUS:79958795290

VL - 30

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 6

M1 - E2

ER -